Joseph, Theresita
Auger, Stephen D.
Peress, Luisa
Rack, Daniel
Cuzick, Jack
Giovannoni, Gavin
Lees, Andrew
Schrag, Anette E.
Noyce, Alastair J.
Article History
Received: 13 February 2019
Revised: 17 April 2019
Accepted: 23 April 2019
First Online: 3 May 2019
Compliance with ethical standards
:
: Alastair Noyce holds research grants from Parkinson’s UK, the Leonard Wolfson Experimental Neurology Centre, the UCL Movement Disorders Centre, and the Virginia Kieley Benefaction. He has received personal fees from Britannia Pharmaceuticals and Profile Pharmaceuticals. Andrew Lees is funded by the Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology and reports consultancies from: Britannia Pharmaceuticals and BIAL Portela. He also reports grants and/or research support from the Frances and Renee Hock Fund, and honoraria from Britannia, Profile Pharma, UCB, Roche, BIAL, STADA Nordic, Nordiclnfu Care, and NeuroDerm. Anette Schrag was supported by the National Institute for Health Research University College London Hospitals Biomedical Research Centre, and reports grants from Economic and Social Research Council, GE Healthcare, Parkinson's UK, European Commission, Movement Disorders Society, National Institute of Health and the Royal Free Hospital charity, and received personal fees from Medtronic. The remaining authors declare that they have no conflict of interest.
: The study was conducted with the approval of the local research ethics committee and has been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study.